DOMINIQUE MOORE: Open Payments
NPI 1366966459 · BAYTOWN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 32 payments from 12 companies in 2025. Trend: 2023 $427 · 2024 $269 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $143 |
| Lilly USA, LLC | 9 | $139 |
| Cipher Pharmaceuticals US LLC | 1 | $82 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| Novo Nordisk Inc | 2 | $40 |
| Astellas Pharma US Inc | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Biogen, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: JARDIANCE, OTEZLA, Natroba, REPATHA, Veozah, LEQVIO, AIRSUPRA, Rybelsus.
Industry payments across TX — which companies pay providers there.
